Cubist Systematic Strategies, LLC Pardes Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.4 - $1.95 $18,368 - $25,584
13,120 New
13,120 $23,000
Q2 2022

Aug 15, 2022
SELL
$2.84 - $8.57 $109,340 - $329,945
-38,500 Reduced 83.15%
7,800 $24,000
Q1 2022

May 16, 2022
BUY
$5.64 - $15.64 $248,690 - $689,630
44,094 Added 1998.82%
46,300 $334,000
Q4 2021

Feb 14, 2022
BUY
$9.8 - $17.02 $21,618 - $37,546
2,206 New
2,206 $36,000

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email